Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Inventory (2016 - 2025)

Haemonetics has reported Inventory over the past 16 years, most recently at $321.2 million for Q4 2025.

  • Quarterly results put Inventory at $321.2 million for Q4 2025, up 1316.61% from a year ago — trailing twelve months through Dec 2025 was $321.2 million (up 1316.61% YoY), and the annual figure for FY2025 was $365.1 million, up 15.11%.
  • Inventory for Q4 2025 was $321.2 million at Haemonetics, down from $336.2 million in the prior quarter.
  • Over the last five years, Inventory for HAE hit a ceiling of $382.1 million in Q3 2024 and a floor of -$26.4 million in Q4 2024.
  • Median Inventory over the past 5 years was $311.5 million (2022), compared with a mean of $296.4 million.
  • Biggest five-year swings in Inventory: tumbled 108.68% in 2024 and later skyrocketed 1316.61% in 2025.
  • Haemonetics' Inventory stood at $322.7 million in 2021, then fell by 20.74% to $255.8 million in 2022, then increased by 18.87% to $304.0 million in 2023, then tumbled by 108.68% to -$26.4 million in 2024, then skyrocketed by 1316.61% to $321.2 million in 2025.
  • The last three reported values for Inventory were $321.2 million (Q4 2025), $336.2 million (Q3 2025), and $360.5 million (Q2 2025) per Business Quant data.